Search results
Jun 6, 2024 · Dr. Cathy Eng, Medical Oncologist. Latest Treatment Options for Metastatic Colorectal Cancer. HER2-Targeted Therapy Combination. Fam-Trastuzumab Deruxtecan-nxki (ENHERTU) CodeBreaK 300 Clinical Trial. BREAKWATER Trial. Trending to More Personalized Treatment. KRAS- and EGFR-Targeted Therapy. Bevacizumab.
May 30, 2024 · Paolo Ghia, MD, PhD. Ibrutinib (Imbruvica) given in combination with venetoclax (Venclexta) showed clinically meaningful progression-free survival (PFS) and deep remission rates in chronic lymphocytic leukemia (CLL) and/or small lymphocytic lymphoma (SLL), according to 5-year follow-up data from the phase 2 CAPTIVATE trial (NCT02910583). 1. In ...
4 days ago · Dr. Koffman’s blog is arguably the most popular, trusted, and accessible beacon for over 20,000 readers every month who have had their lives touched by CLL. As a doctor-turned-CLL-patient, his popular blog and the wide scope of his volunteer efforts in other community and online patient advocacy and education has added an increasingly ...
Jun 3, 2024 · Our Story. In 2005, when Dr. Brian Koffman was diagnosed with CLL, he and his wife, Patty, sought to define and acquire the best possible care for one CLL patient: Brian. Uncovering critical, unmet needs within the CLL community, t hey created the non-profit CLL Society to function as a conduit, making vital support and credible, cutting-edge ...
5 days ago · She is an expert panelist for the National Comprehensive Cancer Network (NCCN) CLL Guidelines Panel, which establishes and publishes the most widely referenced guidelines for the evaluation and treatment of patients with CLL. Dr. Stephens is also a member of the medical board for CLL Society, which is the largest patient-led CLL group in the ...
Jun 5, 2024 · Overview of Efficacy and Safety Data for Current CLL Treatment Options. EP: 8. Acalabrutinib-Based Treatment Clinical Trial Updates. EP: 9. Venetoclax-Based Treatment Clinical Trial Updates. EP: 10. Zanubrutinib-Based Treatment Clinical Trial Updates. EP: 11. Ibrutinib-Based Treatment Clinical Trial Updates.
4 days ago · Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the Western world. Treatment selection in CLL is dependent upon a patient's prognostic factors, such as his or her age and genetic mutations, and can be a challenging decision. Several novel agents are available, making treatment selection and ...
